7052 related articles for article (PubMed ID: 22304773)
1. [Antitumoral efficacy by systemic delivery of cationic liposome-plasmid interleukin-15 complexes in murine models of lung metastasis].
Teng X; Zhou XK; Zhang YB; Qiu J; Mao YQ; Deng HX; Li J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Feb; 28(2):148-52. PubMed ID: 22304773
[TBL] [Abstract][Full Text] [Related]
2. Antitumoral efficacy by systemic delivery of heparin conjugated polyethylenimine-plasmid interleukin-15 complexes in murine models of lung metastasis.
Zhou X; Li X; Gou M; Qiu J; Li J; Yu C; Zhang Y; Zhang N; Teng X; Chen Z; Luo C; Wang Z; Liu X; Shen G; Yang L; Qian Z; Wei Y; Li J
Cancer Sci; 2011 Jul; 102(7):1403-9. PubMed ID: 21564417
[TBL] [Abstract][Full Text] [Related]
3. IL15 combined with Caspy2 provides enhanced therapeutic efficiency against murine malignant neoplasm growth and metastasis.
Yang Y; Zhang XM; Zhang N; Cheng L; Li C; Zhang S; Zhang JF; Dai L; Tian HW; Yan N; Fan P; Dai LX; Xu F; Shi G; Chen XL; Du T; Li YM; Wei YQ; Deng HX
Cancer Gene Ther; 2012 Jul; 19(7):460-7. PubMed ID: 22539063
[TBL] [Abstract][Full Text] [Related]
4. Combined vaccination with major histocompatibility class I and interleukin 2 gene-transduced melanoma cells synergizes the cure of postsurgical established lung metastases.
Porgador A; Tzehoval E; Vadai E; Feldman M; Eisenbach L
Cancer Res; 1995 Nov; 55(21):4941-9. PubMed ID: 7585534
[TBL] [Abstract][Full Text] [Related]
5. [Combination therapy of experimental murine hepatoma with mIL-12 gene and MHC I gene mediated by liposome].
Wang KM; Xia AD; Chen SS
Ai Zheng; 2002 Oct; 21(10):1041-6. PubMed ID: 12508639
[TBL] [Abstract][Full Text] [Related]
6. Antitumor activity of systemically delivered ribozymes targeting murine telomerase RNA.
Nosrati M; Li S; Bagheri S; Ginzinger D; Blackburn EH; Debs RJ; Kashani-Sabet M
Clin Cancer Res; 2004 Aug; 10(15):4983-90. PubMed ID: 15297398
[TBL] [Abstract][Full Text] [Related]
7. Cationic liposomes with plasmid DNA influence cancer metastatic capability.
Ota T; Maeda M; Tatsuka M
Anticancer Res; 2002; 22(6C):4049-52. PubMed ID: 12553031
[TBL] [Abstract][Full Text] [Related]
8. Significant antitumor effects obtained by autologous tumor cell vaccine engineered to secrete interleukin (IL)-12 and IL-18 by means of the EBV/lipoplex.
Asada H; Kishida T; Hirai H; Satoh E; Ohashi S; Takeuchi M; Kubo T; Kita M; Iwakura Y; Imanishi J; Mazda O
Mol Ther; 2002 May; 5(5 Pt 1):609-16. PubMed ID: 11991752
[TBL] [Abstract][Full Text] [Related]
9. Enhanced growth inhibition of metastatic lung tumors by intravenous injection of ATRA-cationic liposome/IL-12 pDNA complexes in mice.
Charoensit P; Kawakami S; Higuchi Y; Yamashita F; Hashida M
Cancer Gene Ther; 2010 Jul; 17(7):512-22. PubMed ID: 20414324
[TBL] [Abstract][Full Text] [Related]
10. Novel cationic liposomes provide highly efficient delivery of DNA and RNA into dendritic cell progenitors and their immature offsets.
Markov OO; Mironova NL; Maslov MA; Petukhov IA; Morozova NG; Vlassov VV; Zenkova MA
J Control Release; 2012 Jun; 160(2):200-10. PubMed ID: 22155599
[TBL] [Abstract][Full Text] [Related]
11. Growth inhibition of established B16-F10 lung metastases by sequential aerosol delivery of p53 gene and 9-nitrocamptothecin.
Gautam A; Waldrep JC; Densmore CL; Koshkina N; Melton S; Roberts L; Gilbert B; Knight V
Gene Ther; 2002 Mar; 9(5):353-7. PubMed ID: 11938455
[TBL] [Abstract][Full Text] [Related]
12. Plasmid DNA-induced cytokines together with cyclophosphamide decrease size and number of melanoma lung metastases.
Cichon T; Smolarczyk R; Sochanik A; Szala S
Anticancer Res; 2006; 26(3A):2033-6. PubMed ID: 16827141
[TBL] [Abstract][Full Text] [Related]
13. Endogenous and adoptively transferred A-NK and T-LAK cells continuously accumulate within murine metastases up to 48 h after inoculation.
Hokland M; Kjaergaard J; Kuppen PJ; Nannmark U; Agger R; Hokland P; Basse P
In Vivo; 1999; 13(3):199-204. PubMed ID: 10459491
[TBL] [Abstract][Full Text] [Related]
14. Enhanced suppression of pulmonary metastasis of malignant melanoma cells by combined administration of alpha-galactosylceramide and interleukin-18.
Nishio S; Yamada N; Ohyama H; Yamanegi K; Nakasho K; Hata M; Nakamura Y; Fukunaga S; Futani H; Yoshiya S; Ueda H; Taniguchi M; Okamura H; Terada N
Cancer Sci; 2008 Jan; 99(1):113-20. PubMed ID: 17949451
[TBL] [Abstract][Full Text] [Related]
15. Plasmid DNA gene therapy: studies with the human interleukin-2 gene in tumor cells in vitro and in the murine B16 melanoma model in vivo.
Parker SE; Khatibi S; Margalith M; Anderson D; Yankauckas M; Gromkowski SH; Latimer T; Lew D; Marquet M; Manthorpe M; Hobart P; Hersh E; Stopeck AT; Norman J
Cancer Gene Ther; 1996; 3(3):175-85. PubMed ID: 8725882
[TBL] [Abstract][Full Text] [Related]
16. [Antitumor and antimetastatic activities of plasmid pcDNA3. 1-IP10 complexed with cationic liposome in mice with 4T1 breast cancer].
Tang QQ; Shi W; Lü HM; Peng XC; Wen YJ
Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Mar; 40(2):195-8. PubMed ID: 19462888
[TBL] [Abstract][Full Text] [Related]
17. Characterization of interleukin-15 gene-modified human natural killer cells: implications for adoptive cellular immunotherapy.
Zhang J; Sun R; Wei H; Zhang J; Tian Z
Haematologica; 2004 Mar; 89(3):338-47. PubMed ID: 15020274
[TBL] [Abstract][Full Text] [Related]
18. Development of cationic liposome formulations for intratracheal gene therapy of early lung cancer.
Zou Y; Zong G; Ling YH; Perez-Soler R
Cancer Gene Ther; 2000 May; 7(5):683-96. PubMed ID: 10830716
[TBL] [Abstract][Full Text] [Related]
19. In vivo cytokine gene therapy of human tumor xenografts in SCID mice by liposome-mediated DNA delivery.
Egilmez NK; Cuenca R; Yokota SJ; Sorgi F; Bankert RB
Gene Ther; 1996 Jul; 3(7):607-14. PubMed ID: 8818648
[TBL] [Abstract][Full Text] [Related]
20. [Antitumor efficacy of the recombinant Newcastle disease virus rNDV-IL15 on melanoma models].
Niu ZS; Bai FL; Sun T; Tian H; Yin JC; Cao HW; Yu D; Tian GY; Wu YZ; Li DS; Ren GP
Yao Xue Xue Bao; 2014 Mar; 49(3):310-5. PubMed ID: 24961100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
